| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 08/13/1992 | DE4103649A1 Neue antikoagulatorisch wirksame peptide New anticoagulatory peptide |
| 08/13/1992 | CA2103703A1 Peptides |
| 08/12/1992 | EP0498784A2 Inhibitors of retroviral protease |
| 08/12/1992 | EP0498771A2 MSH peptide derivatives |
| 08/12/1992 | EP0498658A2 Composition for inducing humoral anergy to an immunogen |
| 08/12/1992 | EP0498508A1 Factor IIa inhibitors |
| 08/12/1992 | EP0498268A2 5-Oxo-L-proline derivatives and pharmaceutical use thereof |
| 08/12/1992 | EP0498069A2 New use of peptide derivative |
| 08/12/1992 | EP0497867A1 Polypeptide inhibitors of gamma interferon |
| 08/12/1992 | EP0497794A1 A microperoxidase preparation containing a hemopeptide as an active component. |
| 08/12/1992 | EP0494955A4 Cell-free synthesis and isolation of novel genes and polypeptides |
| 08/12/1992 | EP0463081A4 Hormone response element compositions and assay |
| 08/12/1992 | CA2060741A1 Gm-csf inhibiting oligopeptides |
| 08/12/1992 | CA2060699A1 Gm-csf inhibiting oligopeptides |
| 08/11/1992 | US5138036 Inhibits growth of leukemia |
| 08/11/1992 | US5138035 Enzyme inhibitors |
| 08/11/1992 | US5137874 For parenteral administration |
| 08/11/1992 | US5137873 Substance p and tachykinin agonists for treatment of alzheimer's disease |
| 08/11/1992 | US5137813 Process for production of an antibiotic compound using zalerion arboricola |
| 08/09/1992 | WO1992013946A1 Htlv-i and htlv-ii peptide antigens and methods |
| 08/09/1992 | WO1992013558A1 A composition for inducing humoral anergy |
| 08/08/1992 | CA2060785A1 Inhibitors of retroviral protease |
| 08/06/1992 | WO1992013090A1 Trans-splicing ribozymes |
| 08/06/1992 | WO1992013089A1 Cell ablation using trans-splicing ribozymes |
| 08/06/1992 | WO1992012996A2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 08/06/1992 | CA2101065A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 08/06/1992 | CA2100068A1 Trans-splicing ribozymes |
| 08/05/1992 | WO1992013877A1 Factor iia inhibitors |
| 08/05/1992 | EP0497585A2 Method of immobilizing and crosslinking proteins and other molecules and uses thereof |
| 08/05/1992 | EP0497368A1 CNP analog peptides and their use |
| 08/05/1992 | EP0497366A2 Antimicrobial peptides and their use against plant pathogens |
| 08/05/1992 | EP0217919B1 Type-specific papillomavirus dna sequences and peptides |
| 08/05/1992 | CA2101331A1 Factor iia inhibitors |
| 08/04/1992 | US5136019 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
| 08/04/1992 | US5135913 Increasing subcutaneous fat by administering copper-peptide complex |
| 08/04/1992 | CA1305931C Yeast strains producing cellulolytic enzymes and methods and means for constructing them |
| 08/02/1992 | WO1992013569A1 Targeted polymeric conjugates of cyclosporin and method for their preparation |
| 08/02/1992 | CA2079590A1 Targeted polymeric conjugates of cyclosporin and method for their preparation |
| 08/01/1992 | WO1992013545A1 Endothelin converting enzyme inhibitors |
| 08/01/1992 | CA2100171A1 Endothelin converting enzyme inhibitors |
| 07/31/1992 | CA2060235A1 Method of immobilizing and crosslinking proteins and other molecules and uses thereof |
| 07/29/1992 | EP0496452A1 Novel endothelin receptor antagonists isolated from microbispora |
| 07/29/1992 | EP0496162A2 Peptide inhibitors of RAS-GAP interaction |
| 07/29/1992 | EP0496013A1 Synthetic peptide derived from human lipocortin V and use thereof |
| 07/29/1992 | EP0495896A1 Vaccines for protecting against infections by hiv virus;process for producing the same and their use as diagnostic and immunotherapy means. |
| 07/29/1992 | EP0495836A1 Dye transfer inhibition. |
| 07/29/1992 | CN1063110A Amedes of antibiotic ge 2270 factors |
| 07/29/1992 | CN1063109A Improvements in and relating to hormones |
| 07/28/1992 | US5133866 Method to identify analyte-bending ligands |
| 07/28/1992 | CA1305828C Synthetic peptides and use for diagnosis and vaccination for aids and arc |
| 07/28/1992 | CA1305678C Recombinant dna clone encoding laminin receptor |
| 07/26/1992 | WO1992013094A1 Process for producing cyclosporin a and/or c |
| 07/26/1992 | WO1992012727A1 Laminin a chain domain vi polypeptides |
| 07/26/1992 | CA2101777A1 Process for producing cyclosporin a and/or c |
| 07/26/1992 | CA2101052A1 Laminin a chain domain vi polypeptides |
| 07/25/1992 | CA2059380A1 Endothelin receptor antagonists isolated from microbispora |
| 07/23/1992 | WO1992012172A1 Amides of antibiotic ge 2270 factors |
| 07/23/1992 | WO1992012170A1 Inhibitions of endothelin formation |
| 07/23/1992 | WO1992012167A1 Protection group, compoud protected by this group and device for grafting the protection group onto the compound being protected |
| 07/23/1992 | CA2099120A1 Protection group, compound protected by this group and device for grafting the protection group onto the compound being protected |
| 07/22/1992 | EP0494955A1 Cell-free synthesis and isolation of novel genes and polypeptides |
| 07/22/1992 | CA2034618A1 Synthetic peptide derived from human lipocortin v and use thereof |
| 07/21/1992 | CA1305414C Process for preparing an improved composition of the zinc salt of bacitracin for veterinary use as growth promoter |
| 07/18/1992 | CA2100579A1 Cell ablation using trans-splicing ribozymes |
| 07/15/1992 | EP0494515A1 Antibiotic cyclic hexapeptide |
| 07/15/1992 | EP0494502A1 Method for surmising functional site in physiologically active polypeptide or polynucleotide |
| 07/15/1992 | EP0494265A1 Rheumatoid factor activity encoded by variant immunoglobulin variable region |
| 07/14/1992 | US5130414 Isolation and structural elucidation of the cyclic peptide hymenistatin 1 |
| 07/14/1992 | US5130253 DNAs Encoding mosquito oostatic hormones |
| 07/14/1992 | CA1305287C Inhibitor peptides |
| 07/14/1992 | CA1305175C2 N-t-butoxycarbonyl-(s)-3-amino-(r)-2-hydroxy-4- phenylbutyronitrile and its production process |
| 07/14/1992 | CA1305084C Polypeptides with fibronectin activity |
| 07/10/1992 | WO1992012247A1 Analogs of piscine lhrh |
| 07/10/1992 | CA2100057A1 Analogs of piscine lhrh |
| 07/09/1992 | WO1992011288A1 Hexapeptides deriving from aglucoteicoplanin and a process for preparing them |
| 07/09/1992 | WO1992011287A1 Vasopressin and vasotocin derivates |
| 07/08/1992 | EP0494078A1 Amides of antibiotic ge 2270 factors |
| 07/08/1992 | EP0493770A2 Antiherpes compositions |
| 07/08/1992 | EP0493506A1 Chimeric amino acids and peptides containing these analogues |
| 07/08/1992 | EP0493498A1 Medicament comprising antamanide |
| 07/08/1992 | EP0187858B1 Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein |
| 07/07/1992 | US5128447 Synthetic peptide antagonists of neurokinin a, salts thereof and respective preparation processes |
| 07/07/1992 | US5128319 Prophylaxis and therapy of acquired immunodeficiency syndrome |
| 07/07/1992 | CA1304886C Metal chelate resins |
| 07/05/1992 | WO1992012169A1 Pseudomonas peptide composition and method for producing the same |
| 07/01/1992 | EP0491861A1 Prophylaxis and therapy of acquired immunodeficiency syndrome |
| 07/01/1992 | EP0491844A1 Peptides including ctl epitopes of hiv proteins and use thereof |
| 07/01/1992 | EP0491828A1 PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP), DIAGNOSTIC AND THERAPEUTIC USE THEREOF |
| 06/28/1992 | WO1992012171A1 New synthethic peptides with imunomodulating activity and preparation thereof |
| 06/28/1992 | WO1992012168A1 Modified hexa- and heptapeptide anaphylatoxin receptor ligands |
| 06/28/1992 | WO1992011858A1 Hexa- and heptapeptide anaphylatoxin-receptor ligands |
| 06/28/1992 | CA2095360A1 Modified hexa- and heptapeptide anaphylatoxin receptor ligands |
| 06/28/1992 | CA2095359A1 Hexa- and heptapeptide anaphylatoxin receptor ligands |
| 06/28/1992 | CA2076877A1 Synthetic peptides with immunomodulating activity and their preparation |
| 06/25/1992 | WO1992010587A1 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 06/25/1992 | WO1992010567A1 Synthetic bioadhesive polypeptide |
| 06/25/1992 | WO1992010514A2 Synthetic antigens for the detection of antibodies to hepatitis c virus |
| 06/25/1992 | WO1992010513A1 Subunit papillomavirus vaccine and peptides for use therein |
| 06/25/1992 | WO1992010511A1 Compounds and compositions which inhibit bone resorption |
| 06/25/1992 | WO1992010510A1 Dithiolano- and dithianoglycin-containing renin-inhibiting peptides, process for producing the same and their use in medicaments |